The Blood Grouping Reagents Market in Australia showed a declining trend in value per capita from 2012 to 2022. From 2012 to 2014, slight fluctuations occurred, but a significant decline began in 2015. By 2022, the per capita value reached $0.41, indicating a considerable year-on-year decrease. The decrease from 2020 to 2022 was approximately 11.54% year-on-year. Over the last five years, the Compound Annual Growth Rate (CAGR) was around -6.95%. As of 2023, the market showed $0.40 per capita.
Future trends to watch for include potential market stabilization due to technological advancements and healthcare innovations which might counteract the previous decline. Additionally, policy changes and increased focus on personalized medicine could impact market dynamics positively by enhancing demand for precise and reliable blood grouping reagents.
| # | 13 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Spain | 2.14 | 2023 | View data | ||
| 2 | 2 United Kingdom | 1.64 | 2023 | View data | ||
| 3 | 3 Italy | 1.52 | 2023 | View data | ||
| 4 | 4 Greece | 1.35 | 2023 | View data | ||
| 5 | 5 Croatia | 1.01 | 2023 | View data | ||
| 9 | 9 Poland | 0.59 | 2023 | View data | ||
| 10 | 10 Lithuania | 0.48 | 2023 | View data | ||
| 11 | 11 Australia | 0.36 | 2023 | |||
| 12 | 12 Thailand | 0.3 | 2023 | View data | ||
| 13 | 13 Brazil | 0.16 | 2023 | View data | ||
